Harper E A, Shankley N P, Black J W
James Black Foundation, Dulwich, London, UK.
Br J Pharmacol. 2007 May;151(1):128-43. doi: 10.1038/sj.bjp.0707174. Epub 2007 Mar 12.
Agonist apparent affinities (pK(I)') in histamine H(3)-receptor binding assays were higher than expected from apparent affinity values (pK(app)) estimated in bioassay. Here, we investigate whether the degree of pK(I)' overestimation is related to agonist intrinsic efficacy, by studying the effect of buffer composition on the pK(I)' of ligands with varying intrinsic activity.
In the guinea-pig ileum bioassay, intrinsic activity (alpha) was determined from the maximal inhibition of the contraction produced by increasing agonist concentration. pK(app) values were estimated using the method of Furchgott. The pK(L) of [(3)H]clobenpropit in guinea-pig cerebral cortex was estimated by saturation analysis in 20 mM HEPES-NaOH buffer (buffer B(0,0,0)), or buffer B(0,0,0) containing 70 mM CaCl(2), 100 mM NaCl and 100 mM KCl (buffer B(0.07,0.1,0.1)). PK(I) values were determined in competition studies in both buffers.
[(3)H]clobenpropit saturation isotherms had n (H) values of unity in both buffers. In buffer B(0.07,0.1,0.1), agonist pK(I)' values were closer to pK(app) values than in buffer B(0,0,0) but were associated with n (H) values <1. A two-site analysis of agonist data in buffer B(0.07, 0.1, 0.1) provided a better fit than a one-site fit and low affinity values (pK(IL)) were comparable to pK(app). Differences between the pK(I)' in buffer B(0,0,0) and pK(IL) values in buffer B(0.07,0.1,0.1) (DeltapK) were correlated with alpha.
H(3)-receptor binding assays conducted in buffer B(0,0,0) and buffer B(0.07,0.1,0.1) can provide a measure of ligand affinity (pK(app)) and intrinsic efficacy. The assay predicts that some ligands previously classified as H(3)-receptor antagonists may possess residual intrinsic efficacy.
在组胺H3受体结合试验中,激动剂的表观亲和力(pK(I)')高于生物测定中估计的表观亲和力值(pK(app))。在此,我们通过研究缓冲液组成对具有不同内在活性的配体pK(I)'的影响,来探究pK(I)'高估程度是否与激动剂内在效能有关。
在豚鼠回肠生物测定中,通过增加激动剂浓度产生的收缩最大抑制来确定内在活性(α)。使用Furchgott方法估计pK(app)值。通过在20 mM HEPES-NaOH缓冲液(缓冲液B(0,0,0))或含有70 mM CaCl2、100 mM NaCl和100 mM KCl的缓冲液B(0,0,0)(缓冲液B(0.07,0.1,0.1))中的饱和分析来估计豚鼠大脑皮层中[(3)H]氯苯丙醇的pK(L)。在两种缓冲液的竞争研究中确定pK(I)值。
[(3)H]氯苯丙醇饱和等温线在两种缓冲液中的n(H)值均为1。在缓冲液B(0.07,0.1,0.1)中,激动剂pK(I)'值比在缓冲液B(0,0,0)中更接近pK(app)值,但与n(H)值<1相关。对缓冲液B(0.07,0.1,0.1)中激动剂数据的双位点分析比单位点拟合提供了更好的拟合,且低亲和力值(pK(IL))与pK(app)相当。缓冲液B(0,0,0)中的pK(I)'与缓冲液B(0.07,0.1,0.1)中的pK(IL)值之间的差异(ΔpK)与α相关。
在缓冲液B( (0,0,0)和缓冲液B(0.07,0.1,0.1)中进行的H3受体结合试验可以提供配体亲和力(pK(app))和内在效能的度量。该试验预测,一些先前被归类为H3受体拮抗剂的配体可能具有残余内在效能。